Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Tremfya (guselkumab)
pCPA File Number:
21013
Negotiation Status:
Concluded without agreement
Indication(s):
Psoriasis, moderate to severe plaque
Sponsor/Manufacturer:
Janssen Inc.
CADTH Project Number:
SR0530-000
pCPA Engagement Letter Issued:
2018-10-30
Negotiation Process Concluded:
2019-06-21